 | | PRD_000180 | | Name: | N-carboxyphenylalanyl-N~5~-[amino(iminio)methyl]ornithyl-N-[(2S)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-valinamide | | Formula: | C27 H47 N10 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2025-06-16 |
|
 | | PRD_002534 | | Name: | Inhibitor YBX-PHE-VAL-GLY-THR-THR-PHA-MAA-BIF-EME-NEH | | Formula: | C64 H84 N10 O14 S | | Definition date: | 2025-03-26 | | Last modified: | 2025-03-26 |
|
 | | PRD_002560 | | Name: | Entolysin A | | Formula: | C81 H141 N17 O23 | | Description: | D-Ser, L-Val, L-Leu, D-Ser, L-Ile amino acids make up a macrocycle within the peptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002561 | | Name: | Orfamide A | | Formula: | C64 H114 N10 O17 | | Description: | Cyclic lipopeptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002363 | | Formula: | C73 H120 N20 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2025-02-04 |
|
 | | PRD_002367 | | Name: | ~{N}-[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]-1-methyl-4-[3-[[1-methyl-4-[[1-methyl-4-[3-[[1-methyl-4-[(1-methylimidazol-2-yl)carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazol-2-yl]carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazole-2-carboxamide | | Formula: | C41 H55 N17 O8 | | Definition date: | 2022-08-03 | | Last modified: | 2025-02-04 |
|
 | | PRD_002397 | | Formula: | C41 H72 N14 O10 S | | Definition date: | 2021-03-31 | | Last modified: | 2025-02-04 |
|
 | | PRD_002111 | | Name: | ADEP-2B5Me | | Formula: | C41 H56 F2 N6 O8 | | Definition date: | 2014-10-08 | | Last modified: | 2024-12-19 |
|
 | | PRD_002551 | | Name: | Alisporivir | | Formula: | C63 H113 N11 O12 | | Description: | Analogue of cyclosporine A. It is a cyclic undecapeptide. Cyclization is achieved by linking the N- and the C- termini. | | Definition date: | 2024-10-30 | | Last modified: | 2024-10-30 |
|
 | | PRD_002553 | | Name: | Dihydrocyclosporin A | | Formula: | C62 H113 N11 O12 | | Description: | Analogue of cyclosporine A. It is a cyclic undecapeptide. Cyclization is achieved by linking the N- and the C- termini. | | Definition date: | 2024-10-30 | | Last modified: | 2024-10-30 |
|
 | | PRD_002519 | | Name: | MCR-PHE-VAL-PRO-THR-THR-BIF-MAA-BIF-MAA-GLU-ALA-PRO-ALA-NEH inhibitor | | Formula: | C85 H110 N14 O18 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002520 | | Name: | ACE-PHE-VAL-DAB-THR-THR-PHE-MAA-BIF-YBR inhibitor | | Formula: | C62 H80 N10 O14 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002521 | | Name: | YBX-YC3-VAL-PRO-THR-THR-PHE-MAA-CYS-MN1 inhibitor | | Formula: | C60 H81 N9 O13 S3 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002525 | | Name: | PPI-YD5-NLE-7T2-SER-7T2-DPP-GLY-NH2 inhibitor | | Formula: | C43 H59 Cl2 N9 O10 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002558 | | Name: | DGN-DVA-YC3-GLU-PRO-THR-THR-PHE-MAA-A1BC0 inhibitor | | Formula: | C62 H84 N12 O14 S2 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002583 | | Name: | Peptidoglycan disaccharide tetrapeptide | | Formula: | C37 H63 N9 O19 | | Description: | Peptidoglycan is composed of glycan strands and peptide stems. In this instance the glycan strands are made of N-acetylmuramic acid/MurNAc (MUB) and N-acetylglucosamine/GlcNAc (NAG) linked by beta-1,4 glycosidic bonds. Peptide stems, in this instance, are attach to MurNAc and consist of L-alanine, gamma D-glutamine/D-Gln (ZGL), meso-diaminopimelic acid/m-DAP (JGO), and D-alanine (DAP). | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002546 | | Name: | NOSO-95179 antibiotic | | Formula: | C43 H79 N18 O11 | | Definition date: | 2024-10-09 | | Last modified: | 2024-10-09 |
|
 | | PRD_002540 | | Name: | evybactin | | Formula: | C64 H91 N21 O21 | | Definition date: | 2024-10-02 | | Last modified: | 2024-10-02 |
|
 | | PRD_002578 | | Name: | (2~{S},3~{R})-~{N}-[(5~{S},8~{S},10~{S})-5-methyl-10-oxidanyl-2,7-bis(oxidanylidene)-1,6-diazacyclododec-8-yl]-3-oxidanyl-2-(3-phenylpropanoylamino)butanamide | | Formula: | C24 H36 N4 O6 | | Definition date: | 2024-09-25 | | Last modified: | 2024-09-25 |
|
 | | PRD_000695 | | Name: | (2S)-1-[2-[(4-hydroxy-4-oxobutanoyl)amino]acetyl]pyrrolidine-2-carboxylic acid | | Formula: | C11 H16 N2 O6 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
 | | PRD_002539 | | Name: | [FIP-HRC]2-PEG11 | | Formula: | C28 H29 N3 O6 | | Definition date: | 2024-07-24 | | Last modified: | 2024-07-24 |
|
 | | PRD_002555 | | Name: | Paenilamicin B2 | | Formula: | C42 H86 N16 O13 | | Description: | Nonribosomally synthesized peptide-polyketide hybrid | | Definition date: | 2024-07-24 | | Last modified: | 2024-07-24 |
|
 | | PRD_002423 | | Name: | Phytochelatin 2 | | Formula: | C18 H29 N5 O10 S2 | | Definition date: | 2024-06-19 | | Last modified: | 2024-06-19 |
|
 | | PRD_002429 | | Name: | cihanmycin G | | Formula: | C74 H87 N11 O22 | | Definition date: | 2024-06-19 | | Last modified: | 2024-06-19 |
|
 | | PRD_002404 | | Name: | Dynobactin A | | Formula: | C60 H78 N18 O16 | | Description: | 10mer peptide with distinct cyclophane rings. | | Definition date: | 2022-09-28 | | Last modified: | 2024-03-26 |
|
